Literature DB >> 20013177

Synthesis and characterization of polymer nanocarriers for the targeted delivery of therapeutic enzymes.

Eric Simone1, Thomas Dziubla, Vladimir Shuvaev, Vladimir R Muzykantov.   

Abstract

Protein drugs, such as recombinant enzymes useful for detoxification and replacement therapies, have extraordinary specificity and potency. However, inherently inadequate delivery to target sites and rapid inactivation limit their medical utility. Using chaperone polymeric particles designed within an injectible size range (sub-micron) may help solve these shortcomings. Such nanocarriers would (i) prevent premature inactivation of encapsulated therapeutic protein cargoes, (ii) provide a carrier that can be surface decorated by targeting ligands, and (iii) optimize sub-cellular localization of the drug. This chapter describes the techniques successfully employed for the preparation of polymer nanocarriers (PNC) loaded with the antioxidant enzyme, catalase, and targeted to endothelial cells. Methods of PNC synthesis, loading with catalase, characterization, coupling of a targeting moiety, and in vitro testing of the enzymatic and targeting activities are provided here. Advantages and disadvantages of specific designs are discussed. Due to the modular nature of the targeting methodology employed, it is believed that these protocols will provide a solid foundation for the formulation of a wide variety of enzymatic drug targeting strategies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20013177      PMCID: PMC3085892          DOI: 10.1007/978-1-60327-029-8_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  34 in total

Review 1.  Pancreatic enzyme replacement therapy.

Authors:  P Layer; J Keller; P G Lankisch
Journal:  Curr Gastroenterol Rep       Date:  2001-04

2.  Streptavidin-biotin crosslinking of therapeutic enzymes with carrier antibodies: nanoconjugates for protection against endothelial oxidative stress.

Authors:  Vladimir V Shuvaev; Thomas Dziubla; Rainer Wiewrodt; Vladimir R Muzykantov
Journal:  Methods Mol Biol       Date:  2004

3.  Characterization of endothelial internalization and targeting of antibody-enzyme conjugates in cell cultures and in laboratory animals.

Authors:  Silvia Muro; Vladimir R Muzykantov; Juan-Carlos Murciano
Journal:  Methods Mol Biol       Date:  2004

Review 4.  Hydrogels for oral delivery of therapeutic proteins.

Authors:  Nicholas A Peppas; Kristy M Wood; James O Blanchette
Journal:  Expert Opin Biol Ther       Date:  2004-06       Impact factor: 4.388

Review 5.  Recent developments of collagen-based materials for medical applications and drug delivery systems.

Authors:  K P Rao
Journal:  J Biomater Sci Polym Ed       Date:  1995       Impact factor: 3.517

Review 6.  Protein delivery with infusion pumps.

Authors:  U Bremer; C R Horres; M L Francoeur
Journal:  Pharm Biotechnol       Date:  1997

Review 7.  Targeting of superoxide dismutase and catalase to vascular endothelium.

Authors:  V R Muzykantov
Journal:  J Control Release       Date:  2001-03-12       Impact factor: 9.776

8.  Endothelial targeting of high-affinity multivalent polymer nanocarriers directed to intercellular adhesion molecule 1.

Authors:  Silvia Muro; Thomas Dziubla; Weining Qiu; John Leferovich; Xiumin Cui; Erik Berk; Vladimir R Muzykantov
Journal:  J Pharmacol Exp Ther       Date:  2006-02-27       Impact factor: 4.030

Review 9.  Interferon-gamma therapy: evaluation of routes of administration and delivery systems.

Authors:  Husam M Younes; Brian G Amsden
Journal:  J Pharm Sci       Date:  2002-01       Impact factor: 3.534

10.  Effect of polymer amphiphilicity on loading of a therapeutic enzyme into protective filamentous and spherical polymer nanocarriers.

Authors:  Eric A Simone; Thomas D Dziubla; Francheska Colon-Gonzalez; Dennis E Discher; Vladimir R Muzykantov
Journal:  Biomacromolecules       Date:  2007-11-27       Impact factor: 6.988

View more
  3 in total

Review 1.  Ferritin-based drug delivery systems: Hybrid nanocarriers for vascular immunotargeting.

Authors:  Makan Khoshnejad; Hamideh Parhiz; Vladimir V Shuvaev; Ivan J Dmochowski; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2018-03-06       Impact factor: 9.776

2.  Surface De-PEGylation Controls Nanoparticle-Mediated siRNA Delivery In Vitro and In Vivo.

Authors:  Xi Zhu; Wei Tao; Danny Liu; Jun Wu; Zilei Guo; Xiaoyuan Ji; Zameer Bharwani; Lili Zhao; Xiaoping Zhao; Omid C Farokhzad; Jinjun Shi
Journal:  Theranostics       Date:  2017-05-12       Impact factor: 11.556

3.  Quercetin conjugated poly(β-amino esters) nanogels for the treatment of cellular oxidative stress.

Authors:  Prachi Gupta; Sundar P Authimoolam; J Zach Hilt; Thomas D Dziubla
Journal:  Acta Biomater       Date:  2015-08-28       Impact factor: 8.947

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.